Delivery Order SPE2DB24D2012-SPE2DB24FBUPH
- Not listed
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply the Department of Defense with Entresto 49 mg-51 mg tablets. The contract, valued at $15,060.89, has a period of performance through March 19, 2024. Amerisourcebergen is the prime contractor and there is no set-aside designation for this award. In addition to this specific delivery order,...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp (a subsidiary of Amerisourcebergen Corporation) to provide Entresto 49 mg-51 mg tablets in 60-count packages. The $14,114.35 award has an ultimate completion date of March 18, 2024. This delivery order falls under a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp by DLA, with a potential value of $999,999,999.00 and a performance period...
- The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide ENTRESTO 24 MG-26 MG tablets in 180 count bottles. The contract has a ceiling value of $15,425.32 and a performance period through April 15, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp, valued at up to $999,999,999.00 through...
- The U.S. Defense Logistics Agency (DLA) awarded a $5,001.44 firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of 4564157403 Entresto 24 mg-26 mg tablets. This delivery order falls under an indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract vehicle...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of the pharmaceutical product ENTRESTO 97 MG-103 MG TABLET 180S. The contract has a ceiling value of $2,384.62 and a period of performance through April 3, 2024. Amerisourcebergen Drug Corp serves as the prime contractor on this delivery order, which is issued under a larger indefinite delivery contract (IDC)...
- The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 180-count bottles of the pharmaceutical drug ENTRESTO 24 MG-26 MG tablets. The firm fixed price delivery order, valued at $2,392.48, has a period of performance through March 2024. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) awarded by DLA, valued up to $999,999,999.00 through...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Entresto 24 mg-26 mg tablets. The $35,443.44 firm-fixed-price contract has an ultimate completion date of August 21, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999 through December 2025, for providing a comprehensive range of...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide ENTRESTO 24 MG-26 MG tablets in 180 count packages. The award has a completion date of February 12, 2024 and a potential value of $1,282.51. Amerisourcebergen Drug Corp, a for-profit organization, serves as the prime contractor on this delivery order, which is not designated as a set-aside contract. Amerisourcebergen Drug Corp...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for $31,342.00 to supply Entresto 24 mg-26 mg tablets (60-count units) under a firm fixed price contract. The award, issued on September 22, 2025, with an ultimate completion date of September 23, 2025, represents a non-set-aside competitive procurement. Performance will be executed from AmerisourceBergen's Conshohocken, Pennsylvania location, where the company maintains its corporate headquarters as a...
- The U.S. Defense Logistics Agency (DLA) awarded a $9,274.86 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office division, a major pharmaceutical distributor, for the supply of 180 tablets of the drug ENTRESTO (97 mg-103 mg). This delivery order contract falls under Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, which enables the agency to efficiently procure a...
- SPE2DB24D2012Indefinite Delivery Contract
- SPE2DB24D2012-SPE2DB24FBUPHDelivery Order
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical distribution company AmerisourceBergen Corporation. The $41,847.64 contract is for the supply of Entresto 24 mg-26 mg tablets in 180-count bottles, with a period of performance through April 1, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp, with a potential value of up to $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary vehicle for AmerisourceBergen to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. No set-aside designation was used for this contract award.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $41.8k | 3/29/24 |